See more : T.T. Limited (TTL.BO) Income Statement Analysis – Financial Results
Complete financial analysis of Outset Medical, Inc. (OM) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Outset Medical, Inc., a leading company in the Medical – Devices industry within the Healthcare sector.
You may be interested
- Jiangxi Black Cat Carbon Black Inc.,Ltd (002068.SZ) Income Statement Analysis – Financial Results
- Evotec SE (0IRF.IL) Income Statement Analysis – Financial Results
- Bank Linth LLB AG (LINN.SW) Income Statement Analysis – Financial Results
- Suzhou Institute of Building Science Group Co.,Ltd (603183.SS) Income Statement Analysis – Financial Results
- Financial 15 Split Corp. (FNNCF) Income Statement Analysis – Financial Results
Outset Medical, Inc. (OM)
About Outset Medical, Inc.
Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 130.38M | 115.38M | 102.60M | 49.94M | 15.08M | 2.01M |
| Cost of Revenue | 101.38M | 97.54M | 94.99M | 62.97M | 32.88M | 8.12M |
| Gross Profit | 29.00M | 17.83M | 7.61M | -13.04M | -17.80M | -6.12M |
| Gross Profit Ratio | 22.24% | 15.46% | 7.42% | -26.11% | -118.07% | -304.68% |
| Research & Development | 57.31M | 48.86M | 36.74M | 28.85M | 23.33M | 22.92M |
| General & Administrative | 45.23M | 40.52M | 36.32M | 30.51M | 8.92M | 6.25M |
| Selling & Marketing | 96.23M | 89.48M | 65.07M | 45.07M | 20.26M | 11.28M |
| SG&A | 141.46M | 130.00M | 101.39M | 75.58M | 29.18M | 17.53M |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 198.77M | 178.85M | 138.13M | 104.43M | 52.51M | 40.45M |
| Cost & Expenses | 300.15M | 276.39M | 233.12M | 167.40M | 85.39M | 48.57M |
| Interest Income | 10.17M | 3.29M | 498.00K | 526.00K | 2.49M | 1.71M |
| Interest Expense | 12.68M | 3.57M | 1.72M | 2.37M | 4.26M | 4.64M |
| Depreciation & Amortization | 5.81M | 6.28M | 6.18M | 3.76M | 1.94M | 1.49M |
| EBITDA | -153.79M | -152.81M | -124.86M | -114.85M | -62.09M | -43.62M |
| EBITDA Ratio | -117.96% | -136.71% | -126.72% | -235.24% | -436.97% | -2,181.61% |
| Operating Income | -169.77M | -161.02M | -130.52M | -117.47M | -70.31M | -46.56M |
| Operating Income Ratio | -130.22% | -139.56% | -127.21% | -235.24% | -466.29% | -2,320.03% |
| Total Other Income/Expenses | -2.50M | -1.64M | -1.22M | -4.03M | 2.03M | -3.19M |
| Income Before Tax | -172.27M | -162.66M | -131.74M | -121.49M | -68.28M | -49.76M |
| Income Before Tax Ratio | -132.14% | -140.98% | -128.40% | -243.30% | -452.84% | -2,479.07% |
| Income Tax Expense | 523.00K | 295.00K | 199.00K | -794.00K | 20.00K | 25.00K |
| Net Income | -172.80M | -162.96M | -131.94M | -120.70M | -68.30M | -49.78M |
| Net Income Ratio | -132.54% | -141.24% | -128.59% | -241.71% | -452.97% | -2,480.32% |
| EPS | -3.48 | -3.38 | -2.89 | -2.83 | -1.61 | -1.65 |
| EPS Diluted | -3.48 | -3.38 | -2.89 | -2.83 | -1.61 | -1.65 |
| Weighted Avg Shares Out | 49.59M | 48.16M | 45.59M | 42.72M | 42.33M | 30.08M |
| Weighted Avg Shares Out (Dil) | 49.59M | 48.16M | 45.59M | 42.72M | 42.33M | 30.08M |
Levi & Korsinsky Notifies Outset Medical, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - OM
NEW YORK, NY / ACCESSWIRE / October 13, 2024 / If you suffered a loss on your Outset Medical, Inc. (NASDAQ:OM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for...
OM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Outset Medical, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
NEW YORK CITY, NY / ACCESSWIRE / October 13, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Outset Medical, Inc. ("Outset Medical" or "the Company")...
Outset Medical, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before October 28, 2024 to Discuss Your Rights - OM
NEW YORK, NY / ACCESSWIRE / October 12, 2024 / If you suffered a loss on your Outset Medical, Inc. (NASDAQ:OM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for...
Outset Medical Inc Is Being Sued For Securities Law Violations And Affected Shareholders Are Urged To Contact The Schall Law Firm
LOS ANGELES, CA / ACCESSWIRE / October 12, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Outset Medical, Inc. ("Outset" or "the Company") (NASDAQ:OM) for violations of 10(b)...
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Outset Medical, Inc.(OM) Shareholders
NEW YORK, NY / ACCESSWIRE / October 11, 2024 / If you suffered a loss on your Outset Medical, Inc. (NASDAQ:OM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for...
OM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Outset Medical, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
NEW YORK, Oct. 11, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Outset Medical, Inc. (“Outset Medical” or “the Company”)...
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Outset Medical, Inc. (OM) Shareholders
NEW YORK, NY / ACCESSWIRE / October 11, 2024 / If you suffered a loss on your Outset Medical, Inc. (NASDAQ:OM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for...
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Outset Medical, Inc. - OM
NEW YORK, NY / ACCESSWIRE / October 11, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Outset Medical, Inc. ("Outset Medical" or the "Company") (NASDAQ:OM). Such investors are advised to contact Danielle Peyton at...
OM Investors Have Opportunity to Lead Outset Medical, Inc. Securities Fraud Lawsuit
LOS ANGELES , Oct. 11, 2024 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Outset Medical, Inc. ("Outset Medical" or the "Company") (NASDAQ:...
Levi & Korsinsky Notifies Shareholders of Outset Medical, Inc. (OM) of a Class Action Lawsuit and an Upcoming Deadline
NEW YORK, NY / ACCESSWIRE / October 11, 2024 / If you suffered a loss on your Outset Medical, Inc. (NASDAQ:OM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for...
Source: https://incomestatements.info
Category: Stock Reports